TwinBeech Capital’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-56,905
Closed -$4.43M 675
2025
Q3
$4.43M Buy
+56,905
New +$4.45M 0.18% 154
2024
Q4
Sell
-240,708
Closed -$15.9M 702
2024
Q3
$15.9M Buy
+240,708
New +$17.5M 0.3% 93
2024
Q1
Sell
-83,528
Closed -$6.37M 643
2023
Q4
$6.37M Sell
83,528
-749,263
-90% -$52.1M 0.1% 238
2023
Q3
$57.7M Buy
832,791
+778,775
+1,442% +$62.6M 1.11% 10
2023
Q2
$5.1M Buy
54,016
+7,462
+16% +$649K 0.1% 237
2023
Q1
$3.85M Sell
46,554
-86,033
-65% -$6.76M 0.08% 280
2022
Q4
$9.89M Sell
132,587
-395,130
-75% -$30.5M 0.19% 152
2022
Q3
$43.6M Buy
527,717
+496,111
+1,570% +$47.7M 1.15% 7
2022
Q2
$3M Buy
+31,606
New +$3.27M 0.13% 173
2021
Q3
Sell
-26,633
Closed -$2.76M 641
2021
Q2
$2.76M Buy
+26,633
New +$2.51M 0.33% 93
2020
Q3
Sell
-4,048
Closed -$280K 477
2020
Q2
$280K Sell
4,048
-3,833
-49% -$272K 0.06% 297
2020
Q1
$496K Sell
7,881
-37,173
-83% -$2.68M 0.2% 154
2019
Q4
$3.5M Buy
+45,054
New +$3.52M 1.01% 15

Other funds holding EW

TwinBeech Capital's EW Position: Q4 2025 in Review

TwinBeech Capital sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 56,905 shares — an estimated $4.43M sold.

TwinBeech Capital first reported a position in EW in Q4 2019 and held it in 13 quarters. The position peaked at $57.7M in Q3 2023. 1,315 funds tracked by Wall St. Rank hold EW as of Q4 2025.

  • TwinBeech Capital reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
  • TwinBeech Capital sold 56,905 Edwards Lifesciences shares in Q4 2025, an estimated $4.43M.
  • TwinBeech Capital first reported a position in Edwards Lifesciences in Q4 2019 and held it in 13 quarters.
  • TwinBeech Capital's Edwards Lifesciences position peaked at $57.7M in Q3 2023.
  • 1,315 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on TwinBeech Capital's 13F filing for Q4 2025, filed 17 Feb 2026.